209 related articles for article (PubMed ID: 26088334)
1. Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.
Kempema AM; Widen JC; Hexum JK; Andrews TE; Wang D; Rathe SK; Meece FA; Noble KE; Sachs Z; Largaespada DA; Harki DA
Bioorg Med Chem; 2015 Aug; 23(15):4737-4745. PubMed ID: 26088334
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives.
Yang Z; Kuang B; Kang N; Ding Y; Ge W; Lian L; Gao Y; Wei Y; Chen Y; Zhang Q
Eur J Med Chem; 2017 Feb; 127():296-304. PubMed ID: 28068601
[TBL] [Abstract][Full Text] [Related]
4. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Karnischky L; Li X; Peterson DR; Howard DS; Jordan CT
Blood; 2005 Jun; 105(11):4163-9. PubMed ID: 15687234
[TBL] [Abstract][Full Text] [Related]
5. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
Hassane DC; Guzman ML; Corbett C; Li X; Abboud R; Young F; Liesveld JL; Carroll M; Jordan CT
Blood; 2008 Jun; 111(12):5654-62. PubMed ID: 18305216
[TBL] [Abstract][Full Text] [Related]
6. Antileukemic activity of aminoparthenolide analogs.
Nasim S; Crooks PA
Bioorg Med Chem Lett; 2008 Jul; 18(14):3870-3. PubMed ID: 18590961
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents.
Ding Y; Yang Z; Ge W; Kuang B; Xu J; Yang J; Chen Y; Zhang Q
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1376-1391. PubMed ID: 30208745
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and Biological Evaluation of Costunolide, Parthenolide, and Their Fluorinated Analogues.
Yang ZJ; Ge WZ; Li QY; Lu Y; Gong JM; Kuang BJ; Xi X; Wu H; Zhang Q; Chen Y
J Med Chem; 2015 Sep; 58(17):7007-20. PubMed ID: 26226279
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
10. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
Guzman ML; Rossi RM; Neelakantan S; Li X; Corbett CA; Hassane DC; Becker MW; Bennett JM; Sullivan E; Lachowicz JL; Vaughan A; Sweeney CJ; Matthews W; Carroll M; Liesveld JL; Crooks PA; Jordan CT
Blood; 2007 Dec; 110(13):4427-35. PubMed ID: 17804695
[TBL] [Abstract][Full Text] [Related]
11. Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia.
Darwish NHE; Sudha T; Godugu K; Bharali DJ; Elbaz O; El-Ghaffar HAA; Azmy E; Anber N; Mousa SA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31163672
[TBL] [Abstract][Full Text] [Related]
12. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.
Steele AJ; Jones DT; Ganeshaguru K; Duke VM; Yogashangary BC; North JM; Lowdell MW; Kottaridis PD; Mehta AB; Prentice AG; Hoffbrand AV; Wickremasinghe RG
Leukemia; 2006 Jun; 20(6):1073-9. PubMed ID: 16628188
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of parthenolide-SAHA hybrids for intervention of drug-resistant acute myeloid leukemia.
Ge W; Liu Z; Sun Y; Wang T; Guo H; Chen X; Li S; Wang M; Chen Y; Ding Y; Zhang Q
Bioorg Chem; 2019 Jun; 87():699-713. PubMed ID: 30953889
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.
Kolev JN; O'Dwyer KM; Jordan CT; Fasan R
ACS Chem Biol; 2014 Jan; 9(1):164-73. PubMed ID: 24206617
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis.
Alwaseem H; Frisch BJ; Fasan R
Bioorg Med Chem; 2018 Apr; 26(7):1365-1373. PubMed ID: 28826596
[TBL] [Abstract][Full Text] [Related]
16. Total syntheses of parthenolide and its analogues with macrocyclic stereocontrol.
Long J; Zhang SF; Wang PP; Zhang XM; Yang ZJ; Zhang Q; Chen Y
J Med Chem; 2014 Aug; 57(16):7098-112. PubMed ID: 25102048
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells.
Ji Q; Ding YH; Sun Y; Zhang Y; Gao HE; Song HN; Yang M; Liu XL; Zhang ZX; Li YH; Gao YD
Oncotarget; 2016 Oct; 7(40):65012-65023. PubMed ID: 27542251
[TBL] [Abstract][Full Text] [Related]
18. Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia.
Albayati ZAF; Janganati V; Chen Z; Ponder J; Breen PJ; Jordan CT; Crooks PA
Bioorg Med Chem; 2017 Feb; 25(3):1235-1241. PubMed ID: 28049618
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anti-invasive activity of parthenolide and 3-isopropyl-2-methyl-4-methyleneisoxazolidin-5-one (MZ-6)--a new compound with α-methylene-γ-lactone motif--on two breast cancer cell lines.
Wyrębska A; Gach K; Szemraj J; Szewczyk K; Hrabec E; Koszuk J; Janecki T; Janecka A
Chem Biol Drug Des; 2012 Jan; 79(1):112-20. PubMed ID: 21992414
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity.
Wang W; Adachi M; Kawamura R; Sakamoto H; Hayashi T; Ishida T; Imai K; Shinomura Y
Apoptosis; 2006 Dec; 11(12):2225-35. PubMed ID: 17051330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
